AzTrials
AzTrials

Dental ImplantNCT07595211

Apically Positioned Flap vs Rolled Flap for Soft Tissue Management During Implant Second-Stage Surgery

A study testing Apically Positioned Flap (APF) and Rolled Flap Technique (RFT) in people with Dental Implant, run by Ohio State University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Patients are being asked to consider joining a research study that looks at two different ways dentists uncover dental implants during a small gum surgery. To join this study, Patients must have two dental implants that are ready to be uncovered. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Dental Implant
What is being tested?
Apically Positioned Flap (APF) and Rolled Flap Technique (RFT)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
No sites listed yet
Study dates
30 Jun 2026to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients between the ages of 18-80.
  • Non-smokers or former smokers with at least a 5-year successful cessation history.
  • Patients with normal systemic health (ASA-I) or well-controlled/stable systemic conditions (ASA-II), such as diabetes with HbA1c < 7.0%, no recent acute myocardial infarction or cerebrovascular accidents within 6 months, or any contraindication for periodontal or implant surgery.
  • Patients who had, or plan to have, 2 non-adjacent implants of the same system placed under a two-stage implant protocol.
  • The diameter discrepancy of the 2 target implants must be less than 1 mm.

Who cannot join

  • Current smokers, or smokers who have quit <5 years prior to study entry.
  • Pregnant or lactating women
  • Patients with substance or alcohol abuse
  • Patients with a history of antiresorptive therapy, head and neck radiotherapy, and chemotherapy for malignant tumors
  • Other systemic conditions or medication affecting wound healing.
  • Poor plaque control with plaque score > 20%
Show all 12Show fewer
  • Active/untreated odontogenic and periodontal infections
  • Implants placed, or planned to be placed, with one-stage implant protocol.
  • The diameter discrepancy of the 2 target implants is equal to or greater than 1 mm (≥ 1 mm).
  • Implants showing signs of early peri-implant bone loss or infection.
  • Severe loss of keratinized tissue (> 50%) at the implant site
  • Non-English speaking individuals for studies involving informed consent.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Olivia Bodnar, DDS contact

6142924641

bodnar.61@buckeyemail.osu.edu

Guo-Liang Cheng, DDS, MS contact

6142924641

cheng.712@osu.edu

About this study

Official title: Peri-Implant Soft Tissue Management During Second-Stage Surgery With Two Different Flap Techniques: A Randomized Controlled Study

Patients are being asked to consider joining a research study that looks at two different ways dentists uncover dental implants during a small gum surgery. To join this study, Patients must have two dental implants that are ready to be uncovered. Both uncovering methods used in this research are normal, safe procedures that dentists already use every day. The purpose of this study is to learn which method helps the gums heal better, stay thicker, and look more natural over time.

If patients decide to participate, the dentist will use one method on one implant and the other method on the second implant so we can compare how each implant heals. The study lasts about one year and includes the uncovering surgery plus scheduled follow-up visits. At these visits, the dentist will gently measure your gums, take pictures, take routine dental X-rays, and use a small camera scanner to check how the gum tissue changes. Patients will also be asked to rate any pain or swelling after surgery.

Read more

Patients may have soreness, swelling, or minor bleeding-these are the same risks patients would have during normal implant care. Patients may or may not personally benefit, but the extra monitoring may help us track the healing closely, and patients' participation can help dentists improve care for future patients.

Patients can receive regular implant treatment without joining the study. The goal of this summary is to help you think about the pros and cons and decide what feels right for patients.

Conditions
Dental Implant
Being tested
Apically Positioned Flap (APF), Rolled Flap Technique (RFT)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apically Positioned Flap (APF)Procedure or surgery

    A flap design used during implant second-stage surgery in which a crestal incision with vertical releases is performed, and the flap is repositioned apically and buccally to increase the width of keratinized tissue around the implant.

  • Rolled Flap Technique (RFT)Procedure or surgery

    A flap design used during implant second-stage surgery in which a pedicled connective tissue portion of the flap is de-epithelialized and rolled toward the buccal aspect to increase peri-implant soft tissue thickness.

Study groups in NCT07595211
Study groupRoleWhat they receive
Apically Positioned Flap (APF)Active comparatorDuring implant second-stage surgery, a crestal incision with vertical releases is used to elevate a flap that is repositioned apically and buccally to increase the width of keratinized tissue around the implant, followed by placement of a healing abutment and suturing.
Receives: Procedure: Apically Positioned Flap (APF)
Rolled Flap Technique (RFT)ExperimentalDuring implant second-stage surgery, a full-thickness flap is elevated, and a pedicled connective tissue portion is de-epithelialized and rolled toward the buccal aspect to increase peri-implant soft tissue thickness, followed by placement of a healing abutment and suturing.
Receives: Procedure: Rolled Flap Technique (RFT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Keratinized Tissue Width

    Keratinized tissue width will be measured clinically in millimeters at the mid-buccal aspect of the implant using a periodontal probe at prespecified follow-up visits.

    Measured: Baseline (second-stage surgery) to 12 months after surgery

  2. Change in Peri-Implant Mucosal Thickness

    Peri-implant mucosal thickness will be assessed by superimposing serial intraoral scan data to quantify changes in buccal soft tissue thickness at implant sites over time.

    Measured: Baseline (second-stage surgery) to 12 months after surgery

Secondary outcomes (8)
  1. Pink Esthetic Score (PES)

    Peri-implant soft tissue esthetics will be evaluated using the Pink Esthetic Score based on standardized clinical photographs, assessing papilla, tissue contour, color, and texture.

    Measured: 3, 6, and 12 months after second-stage surgery

  2. Change in Peri-Implant Soft Tissue Volume

    Three-dimensional soft tissue volume changes will be quantified by superimposing serial intraoral scan data obtained at baseline and follow-up visits.

    Measured: Baseline to 3, 6, and 12 months after second-stage surgery

  3. Early Wound Healing Index

    Early wound healing will be assessed using a standardized healing index based on tissue color, bleeding, granulation tissue, and epithelialization.

    Measured: 1 and 2 weeks after second-stage surgery

  4. Plaque Index (PI)

    Oral hygiene status will be assessed using the plaque index based on clinical examination at peri-implant sites.

    Measured: 1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery

  5. Modified Sulcular Bleeding Index (mSBI)

    Peri-implant soft tissue inflammation will be assessed using the modified sulcular bleeding index during clinical examination.

    Measured: 1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery

  6. Postoperative Pain Score

    Participant-reported pain will be measured using a visual analog scale (VAS, 0-100), where higher scores indicate greater pain intensity.

    Measured: 1 and 2 weeks after second-stage surgery

  7. Postoperative Swelling Score

    Participant-reported swelling will be assessed using a visual analog scale (VAS, 0-100), where higher scores indicate greater perceived swelling.

    Measured: 1 and 2 weeks after second-stage surgery

  8. Change in Peri-Implant Bone Level

    Peri-implant marginal bone levels will be assessed using standardized periapical radiographs and compared between baseline and follow-up.

    Measured: Baseline to 12 months after second-stage surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2026
  2. Study start30 Jun 2026 (estimated)
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is a randomized, split-mouth clinical trial. Each participant has two implants and receives both interventions during second-stage surgery, with one implant site randomly assigned to an apically positioned flap and the other to a rolled flap technique. This within-subject design allows direct comparison of peri-implant soft tissue outcomes while controlling for patient-level variability.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07595211
Sponsor's protocol ID
STUDY20252723
Status last verified
May 2026
First submitted
12 May 2026
Last updated
19 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Apically Positioned Flap (APF) and Rolled Flap Technique (RFT) in people with Dental Implant, run by Ohio State University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Olivia Bodnar, DDS (6142924641, bodnar.61@buckeyemail.osu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Keratinized Tissue Width (time frame: Baseline (second-stage surgery) to 12 months after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in